drugset / Trial / NCT01406925
Safety and Tolerability of a Single Intra-anal Dose of NRL001 in Healthy Volunteers
RandomizedCrossoverDouble-blindTreatment
Summary
This study is conducted to explore the safety and tolerability and plasma pharmacokinetics of NRL001 after single intra-anal dose of 1mL cream at increasing concentrations.
Timeline
- Start
- 2007-04
- Primary completion
- 2007-05
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NRL001 | Small molecule | 0.5 % | Other |
| Subject | NRL001 | Small molecule | 0.75 % | Other |
| Subject | NRL001 | Small molecule | 1 % | Other |
Indications
No indication recorded.